117 related articles for article (PubMed ID: 32051393)
1. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
2. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Ye J; Chu C; Zuo L; Zhang J; Cui X
Cell Death Differ; 2021 Mar; 28(3):932-951. PubMed ID: 33009518
[TBL] [Abstract][Full Text] [Related]
3. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
4. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
[TBL] [Abstract][Full Text] [Related]
5. PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway.
Wang L; Yue Y; Zhang L; Jing M; Ma M; Liu C; Li Y; Xu S; Wang K; Wang X; Fan J; Zhang M
Cell Oncol (Dordr); 2023 Oct; 46(5):1317-1332. PubMed ID: 37126128
[TBL] [Abstract][Full Text] [Related]
6. Combining UBR5 and CD163
Wang C; Hong T; Wang Y; Peng G; Yu Y; Zhang J; Zhuo D; Zheng J; Ma X; Cui X
Cancer Immunol Immunother; 2021 Oct; 70(10):2925-2935. PubMed ID: 33710368
[TBL] [Abstract][Full Text] [Related]
7. TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression.
Xie L; Fang Y; Chen J; Meng W; Guan Y; Gong W
PeerJ; 2023; 11():e16316. PubMed ID: 37927783
[TBL] [Abstract][Full Text] [Related]
8. Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma.
Sakamoto H; Yamasaki T; Sumiyoshi T; Takeda M; Shibasaki N; Utsunomiya N; Arakaki R; Akamatsu S; Kobayashi T; Inoue T; Kamba T; Nakamura E; Ogawa O
Cancer Med; 2021 Jan; 10(1):119-134. PubMed ID: 33107222
[TBL] [Abstract][Full Text] [Related]
9. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
10. Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects.
Kamli H; Owens EP; Vesey DA; Prasanna R; Li L; Gobe GC; Morais C
Biochem Biophys Res Commun; 2022 Jan; 586():42-48. PubMed ID: 34826699
[TBL] [Abstract][Full Text] [Related]
11. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
[No Abstract] [Full Text] [Related]
12. Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma.
Ye J; Huang X; Tian S; Wang J; Wang H; Feng H; Zhao X; Cao S; Xuan Y; Li X; Ma X; Huang Y; Zhang X
Exp Cell Res; 2024 Apr; 437(1):113977. PubMed ID: 38373588
[TBL] [Abstract][Full Text] [Related]
13. RNF43 is a Novel Tumor Suppressor and Prognostic Indicator in Clear Cell Renal Cell Carcinoma.
Zhu D; Zhang L; Shi X; Gao S; Yue C; Zhang L; Bai Y; Wang Q; Okada A; Yasui T; Wang C; Cui X; Zuo L
Oncol Res; 2021 Jul; ():. PubMed ID: 34215350
[TBL] [Abstract][Full Text] [Related]
14. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
[TBL] [Abstract][Full Text] [Related]
15. STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness.
Arévalo J; Campoy I; Durán M; Nemours S; Areny A; Vall-Palomar M; Martínez C; Cantero-Recasens G; Meseguer A
Sci Rep; 2023 Nov; 13(1):19552. PubMed ID: 37945711
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract][Full Text] [Related]
18. PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
Chabanon RM; Morel D; Eychenne T; Colmet-Daage L; Bajrami I; Dorvault N; Garrido M; Meisenberg C; Lamb A; Ngo C; Hopkins SR; Roumeliotis TI; Jouny S; Hénon C; Kawai-Kawachi A; Astier C; Konde A; Del Nery E; Massard C; Pettitt SJ; Margueron R; Choudhary JS; Almouzni G; Soria JC; Deutsch E; Downs JA; Lord CJ; Postel-Vinay S
Cancer Res; 2021 Jun; 81(11):2888-2902. PubMed ID: 33888468
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.
Elie BT; Hubbard K; Pechenyy Y; Layek B; Prabha S; Contel M
Cancer Med; 2019 Aug; 8(9):4304-4314. PubMed ID: 31192543
[TBL] [Abstract][Full Text] [Related]
20. MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via ERK-AP1-MMPs axis.
Wei H; Li Y; Zhang J; Xu C; Wei D; Quan C; Zhu S
Sci Rep; 2024 Apr; 14(1):9411. PubMed ID: 38658579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
